|
New anticoagulants as thromboprophylaxis after total hip or knee replacement |
Hamidi V, Ringerike T, Hagen G, Reikvam A, Klemp M |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Hamidi V, Ringerike T, Hagen G, Reikvam A, Klemp M. New anticoagulants as thromboprophylaxis after total hip or knee replacement. International Journal of Technology Assessment in Health Care 2013; 29(3): 234-243 Indexing Status Subject indexing assigned by NLM MeSH Anticoagulants /economics /therapeutic use; Antithrombins /economics /therapeutic use; Arthroplasty, Replacement, Hip /adverse effects; Arthroplasty, Replacement, Knee /adverse effects; Benzimidazoles /economics /therapeutic use; Cost-Benefit Analysis; Dabigatran; Humans; Morpholines /economics /therapeutic use; Outcome Assessment (Health Care); Patient Safety; Premedication /economics; Rivaroxaban; Thiophenes /economics /therapeutic use; Thromboembolism /prevention & beta-Alanine /analogs & control; derivatives /economics /therapeutic use AccessionNumber 22013036598 Date bibliographic record published 30/08/2013 |
|
|
|